Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4409311?pdf=render |
id |
doaj-fe048d345f2146f3b9f24b26786a70a7 |
---|---|
record_format |
Article |
spelling |
doaj-fe048d345f2146f3b9f24b26786a70a72020-11-25T01:55:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012331110.1371/journal.pone.0123311Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.Martin L DecarisClaire L EmsonKelvin LiMichelle GatmaitanFlora LuoJerome CattinCorelle NakamuraWilliam E HolmesThomas E AngelMarion G PetersScott M TurnerMarc K HellersteinAccumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of 2H2O for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates.http://europepmc.org/articles/PMC4409311?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Martin L Decaris Claire L Emson Kelvin Li Michelle Gatmaitan Flora Luo Jerome Cattin Corelle Nakamura William E Holmes Thomas E Angel Marion G Peters Scott M Turner Marc K Hellerstein |
spellingShingle |
Martin L Decaris Claire L Emson Kelvin Li Michelle Gatmaitan Flora Luo Jerome Cattin Corelle Nakamura William E Holmes Thomas E Angel Marion G Peters Scott M Turner Marc K Hellerstein Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. PLoS ONE |
author_facet |
Martin L Decaris Claire L Emson Kelvin Li Michelle Gatmaitan Flora Luo Jerome Cattin Corelle Nakamura William E Holmes Thomas E Angel Marion G Peters Scott M Turner Marc K Hellerstein |
author_sort |
Martin L Decaris |
title |
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
title_short |
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
title_full |
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
title_fullStr |
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
title_full_unstemmed |
Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
title_sort |
turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic information. We describe here results from a pilot study utilizing in vivo metabolic labeling to measure the turnover rate of hepatic collagen and collagen-associated proteins in plasma for the first time in human subjects. Eight subjects with chronic liver disease were labeled with daily oral doses of 2H2O for up to 8 weeks prior to diagnostic liver biopsy and plasma collection. Tandem mass spectrometry was used to measure the abundance and fractional synthesis rate (FSR) of proteins in liver and blood. Relative protein abundance and FSR data in liver revealed marked differences among subjects. FSRs of hepatic type I and III collagen ranged from 0.2-0.6% per day (half-lives of 4 months to a year) and correlated significantly with worsening histologic fibrosis. Analysis of plasma protein turnover revealed two collagen-associated proteins, lumican and transforming growth factor beta-induced-protein (TGFBI), exhibiting FSRs that correlated significantly with FSRs of hepatic collagen. In summary, this is the first direct measurement of liver collagen turnover in vivo in humans and suggests a high rate of collagen remodeling in advanced fibrosis. In addition, the FSRs of collagen-associated proteins in plasma are measurable and may provide a novel strategy for monitoring hepatic fibrogenesis rates. |
url |
http://europepmc.org/articles/PMC4409311?pdf=render |
work_keys_str_mv |
AT martinldecaris turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT clairelemson turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT kelvinli turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT michellegatmaitan turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT floraluo turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT jeromecattin turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT corellenakamura turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT williameholmes turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT thomaseangel turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT mariongpeters turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT scottmturner turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease AT marckhellerstein turnoverratesofhepaticcollagenandcirculatingcollagenassociatedproteinsinhumanswithchronicliverdisease |
_version_ |
1724982836798160896 |